{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T20:24:06Z","timestamp":1790627046349,"version":"4.1.0"},"reference-count":76,"publisher":"Frontiers Media SA","content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pediatr."],"DOI":"10.3389\/fped.2017.00227","type":"journal-article","created":{"date-parts":[[2017,10,30]],"date-time":"2017-10-30T04:16:28Z","timestamp":1509336988000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":101,"title":["Cognitive and Behavioral Disorders in Children with Neurofibromatosis Type 1"],"prefix":"10.3389","volume":"5","author":[{"given":"Martha Milade","family":"Torres Nupan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Velez Van Meerbeke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia Alejandra","family":"L\u00f3pez Cabra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paula Marcela","family":"Herrera Gomez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2017,10,30]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1002\/ajmg.a.33139","article-title":"Birth incidence and prevalence of tumor-prone syndromes: estimates from a UK family genetic register service","author":"Evans","year":"2010","journal-title":"Am J Med Genet A"},{"key":"B2","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1001\/archderm.141.1.71","article-title":"Prevalence of neurofibromatosis 1 in German children at elementary school enrollment","volume":"141","author":"Lammert","year":"2005","journal-title":"Arch Dermatol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1542\/peds.105.3.608","article-title":"Use of the national institutes of health criteria for diagnosis of neurofibromatosis 1 in children","volume":"105","author":"DeBella","year":"2000","journal-title":"Pediatrics"},{"key":"B4","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1586\/14737175.2014.953931","article-title":"Cognitive and behavioral problems in children with neurofibromatosis type 1: challenges and future directions","volume":"14","author":"Schwetye","year":"2014","journal-title":"Expert Rev Neurother"},{"key":"B5","doi-asserted-by":"publisher","first-page":"e1642","DOI":"10.1542\/peds.2013-1868","article-title":"Neurofibromatosis type 1 and autism spectrum disorder","volume":"132","author":"Garg","year":"2013","journal-title":"Pediatrics"},{"key":"B6","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1111\/j.1469-8749.2012.04399.x","article-title":"Behaviour in children with neurofibromatosis type 1: cognition, executive function, attention, emotion, and social competence","volume":"55","author":"Lehtonen","year":"2013","journal-title":"Dev Med Child Neurol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"e1000097","DOI":"10.1016\/j.ijsu.2010.02.007","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"6","author":"Moher","year":"2009","journal-title":"PLoS Med"},{"key":"B8","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.jcomdis.2011.11.002","article-title":"Articulation in schoolchildren and adults with neurofibromatosis type 1","volume":"45","author":"Cosyns","year":"2012","journal-title":"J Commun Disord"},{"key":"B9","doi-asserted-by":"publisher","first-page":"386","DOI":"10.3389\/fnhum.2014.00386","article-title":"Neurocognitive profiles of learning disabled children with neurofibromatosis type1","volume":"8","author":"Orraca-Castillo","year":"2014","journal-title":"Front Hum Neurosci"},{"key":"B10","doi-asserted-by":"publisher","first-page":"1689","DOI":"10.1177\/0883073812462885","article-title":"Longitudinal analysis of developmental delays in children with neurofibromatosis type 1","volume":"28","author":"Wessel","year":"2013","journal-title":"J Child Neurol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.1111\/dmcn.12769","article-title":"Teaching reading to children with neurofibromatosis type 1: a clinical trial with random assignment to different approaches","volume":"57","author":"Barquero","year":"2015","journal-title":"Dev Med Child Neurol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1177\/0883073812439435","article-title":"Attention skills in children with neurofibromatosis type 1","volume":"28","author":"Isenberg","year":"2013","journal-title":"J Child Neurol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1111\/dmcn.12734","article-title":"Cognition in children with neurofibromatosis type 1: data from a population-based study","volume":"57","author":"Lehtonen","year":"2015","journal-title":"Dev Med Child Neurol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1007\/s00415-012-6620-5","article-title":"Paired associate learning in children with neurofibromatosis type 1: implications for clinical trials","volume":"260","author":"Payne","year":"2013","journal-title":"J Neurol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1037\/neu0000046","article-title":"Reactivity to visual signals in neurofibromatosis type 1: is everything ok?","volume":"28","author":"Michael","year":"2014","journal-title":"Neuropsychology"},{"key":"B16","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/1866-1955-6-4","article-title":"Abnormal late visual responses and alpha oscillations in neurofibromatosis type 1: a link to visual and attention deficits","volume":"6","author":"Ribeiro","year":"2014","journal-title":"J Neurodev Disord"},{"key":"B17","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1111\/dmcn.12361","article-title":"Relationship between cognitive dysfunction, gait, and motor impairment in children and adolescents with neurofibromatosis type 1","volume":"56","author":"Champion","year":"2014","journal-title":"Dev Med Child Neurol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"3131","DOI":"10.1016\/j.ridd.2014.07.059","article-title":"Deficient motor timing in children with neurofibromatosis type 1","volume":"35","author":"Debrabant","year":"2014","journal-title":"Res Dev Disabil"},{"key":"B19","doi-asserted-by":"publisher","first-page":"1310","DOI":"10.1016\/j.ridd.2014.03.021","article-title":"Underlying mechanisms of writing difficulties among children with neurofibromatosis type 1","volume":"35","author":"Gilboa","year":"2014","journal-title":"Res Dev Disabil"},{"key":"B20","doi-asserted-by":"publisher","first-page":"2608","DOI":"10.1016\/j.ridd.2011.06.014","article-title":"Using a virtual classroom environment to describe the attention deficits profile of children with neurofibromatosis type 1","volume":"32","author":"Gilboa","year":"2011","journal-title":"Res Dev Disabil"},{"key":"B21","doi-asserted-by":"publisher","first-page":"1320","DOI":"10.1177\/0883073813517001","article-title":"Planning deficit in children with neurofibromatosis type 1: a neurocognitive trait independent from attention-deficit hyperactivity disorder (ADHD)?","volume":"29","author":"Galasso","year":"2014","journal-title":"J Child Neurol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1111\/j.1469-8749.2012.04357.x","article-title":"Does attention-deficit-hyperactivity disorder exacerbate executive dysfunction in children with neurofibromatosis type 1?","volume":"54","author":"Payne","year":"2012","journal-title":"Dev Med Child Neurol"},{"key":"B23","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1080\/09602011.2014.920262","article-title":"Is there a relationship between executive functions and academic success in children with neurofibromatosis type 1?","volume":"24","author":"Gilboa","year":"2014","journal-title":"Neuropsychol Rehabil"},{"key":"B24","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1080\/87565641.2012.695831","article-title":"The impact of ADHD on the cognitive and academic functioning of children with NF1","volume":"37","author":"Pride","year":"2012","journal-title":"Dev Neuropsychol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1111\/j.1469-8749.2012.04377.x","article-title":"The adverse influence of attention-deficit disorder with or without hyperactivity on cognition in neurofibromatosis type 1","volume":"54","author":"Lidzba","year":"2012","journal-title":"Dev Med Child Neurol"},{"key":"B26","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1080\/21622965.2012.704185","article-title":"Is executive function specifically impaired in children with neurofibromatosis type 1? A neuropsychological investigation of cognitive flexibility","volume":"3","author":"Roy","year":"2014","journal-title":"Appl Neuropsychol Child"},{"key":"B27","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1111\/jir.12248","article-title":"Social functioning and facial expression recognition in children with neurofibromatosis type 1","volume":"60","author":"Allen","year":"2016","journal-title":"J Intellect Disabil Res"},{"key":"B28","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1002\/ajmg.b.32280","article-title":"Prevalence of autism spectrum disorder symptoms in children with neurofibromatosis type 1","author":"Plasschaert","year":"2015","journal-title":"Am J Med Genet B Neuropsychiatr Genet"},{"key":"B29","doi-asserted-by":"publisher","first-page":"1649","DOI":"10.1007\/s10803-014-2321-5","article-title":"Autism spectrum disorder profile in neurofibromatosis type I","volume":"45","author":"Garg","year":"2015","journal-title":"J Autism Dev Disord"},{"key":"B30","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1111\/dmcn.12038","article-title":"Symptomatology of autism spectrum disorder in a population with neurofibromatosis type 1","volume":"55","author":"Walsh","year":"2013","journal-title":"Dev Med Child Neurol"},{"key":"B31","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1212\/01.WNL.0000055090.78351.C1","article-title":"Natural history of cognitive deficits and their relationship to MRI T2-hyperintensities in NF1","volume":"60","author":"Hyman","year":"2003","journal-title":"Neurology"},{"key":"B32","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1007\/s00247-006-0267-2","article-title":"Age-related findings on MRI in neurofibromatosis type 1","volume":"36","author":"Gill","year":"2006","journal-title":"Pediatr Radiol"},{"key":"B33","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1002\/ajmg.a.36338","article-title":"Longitudinal assessment of cognition and T2-hyperintensities in NF1: an 18-year study","author":"Payne","year":"2014","journal-title":"Am J Med Genet A"},{"key":"B34","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1037\/neu0000151","article-title":"Examining the frontal subcortical brain vulnerability hypothesis in children with neurofibromatosis type 1: are T2-weighted hyperintensities related to executive dysfunction?","volume":"29","author":"Roy","year":"2015","journal-title":"Neuropsychology"},{"key":"B35","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1111\/j.1469-8749.2011.04139.x","article-title":"Neurofibromatosis type 1 and cerebellar T2-hyperintensities: the relationship to cognitive functioning","volume":"54","author":"Piscitelli","year":"2012","journal-title":"Dev Med Child Neurol"},{"key":"B36","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1016\/j.clinimag.2016.06.013","article-title":"Relationship between the corpus callosum and neurocognitive disabilities in children with NF-1: diffusion tensor imaging features","volume":"40","author":"Aydin","year":"2016","journal-title":"Clin Imaging"},{"key":"B37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s11689-015-9128-3","article-title":"Cerebral volumetric abnormalities in neurofibromatosis type 1: associations with parent ratings of social and attention problems, executive dysfunction, and autistic mannerisms","volume":"7","author":"Huijbregts","year":"2015","journal-title":"J Neurodev Disord"},{"key":"B38","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1089\/brain.2014.0334","article-title":"Functional connectivity changes and executive and social problems in neurofibromatosis type I","volume":"5","author":"Loitfelder","year":"2015","journal-title":"Brain Connect"},{"key":"B39","doi-asserted-by":"publisher","first-page":"e38785","DOI":"10.1371\/journal.pone.0038785","article-title":"Abnormal brain activation in neurofibromatosis type 1: a link between visual processing and the default mode network","volume":"7","author":"Violante","year":"2012","journal-title":"PLoS One"},{"key":"B40","doi-asserted-by":"publisher","first-page":"1961","DOI":"10.1016\/j.cub.2005.09.043","article-title":"The HMG-CoA reductase inhibitor lovastatin reverses the learning and attention deficits in a mouse model of neurofibromatosis type 1","volume":"15","author":"Li","year":"2005","journal-title":"Curr Biol"},{"key":"B41","doi-asserted-by":"publisher","first-page":"2575","DOI":"10.1212\/WNL.0000000000003435","article-title":"Randomized placebo-controlled study of lovastatin in children with neurofibromatosis type 1","volume":"87","author":"Payne","year":"2016","journal-title":"Neurology"},{"key":"B42","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1016\/S1474-4422(13)70227-8","article-title":"Simvastatin for cognitive deficits and behavioural problems in patients with neurofibromatosis type 1 (NF1-SIMCODA): a randomised, placebo-controlled trial","volume":"12","author":"van der Vaart","year":"2013","journal-title":"Lancet Neurol"},{"key":"B43","doi-asserted-by":"publisher","first-page":"322","DOI":"10.2174\/157015908787386069","article-title":"Dopaminergic and noradrenergic contributions to functionality in ADHD: the role of methylphenidate","volume":"6","author":"Engert","year":"2008","journal-title":"Curr Neuropharmacol"},{"key":"B44","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1055\/s-0034-1368117","article-title":"Pharmacotherapy of attention deficit in neurofibromatosis type 1: effects on cognition","volume":"45","author":"Lidzba","year":"2014","journal-title":"Neuropediatrics"},{"key":"B45","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1186\/s13023-014-0142-4","article-title":"The effect of methylphenidate on neurofibromatosis type 1: a randomised, double-blind, placebo-controlled, crossover trial","volume":"9","author":"Lion-Francois","year":"2014","journal-title":"Orphanet J Rare Dis"},{"key":"B46","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.spen.2006.01.006","article-title":"Cognitive profile of neurofibromatosis type 1","volume":"13","author":"Levine","year":"2006","journal-title":"Semin Pediatr Neurol"},{"key":"B47","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1007\/s11910-996-0036-5","article-title":"Neurofibromatosis type 1: new insights into neurocognitive issues","volume":"6","author":"Acosta","year":"2006","journal-title":"Curr Neurol Neurosci Rep"},{"key":"B48","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1017\/S1355617713001227","article-title":"Cognitive and psychosocial phenotype of young children with neurofibromatosis-1","volume":"20","author":"Klein-Tasman","year":"2014","journal-title":"J Int Neuropsychol Soc"},{"key":"B49","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1080\/09297040701595505","article-title":"An examination of lexical and sublexical reading skills in children with neurofibromatosis type 1","volume":"14","author":"Watt","year":"2008","journal-title":"Child Neuropsychol"},{"key":"B50","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1002\/ajmg.a.33178","article-title":"Speech characteristics in neurofibromatosis type 1","author":"Alivuotila","year":"2010","journal-title":"Am J Med Genet A"},{"key":"B51","doi-asserted-by":"publisher","first-page":"2495","DOI":"10.1016\/j.ridd.2014.06.016","article-title":"Language in young children with neurofibromatosis-1: relations to functional communication, attention, and social functioning","volume":"35","author":"Brei","year":"2014","journal-title":"Res Dev Disabil"},{"key":"B52","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.jcomdis.2013.12.002","article-title":"Auditory temporal processing deficits and language disorders in patients with neurofibromatosis type 1","volume":"48","author":"Batista","year":"2014","journal-title":"J Commun Disord"},{"key":"B53","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1212\/01.wnl.0000179303.72345.ce","article-title":"The nature and frequency of cognitive deficits in children with neurofibromatosis type 1","volume":"65","author":"Hyman","year":"2005","journal-title":"Neurology"},{"key":"B54","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1080\/87565641.2010.508670","article-title":"Cognitive and motor control in neurofibromatosis type I: influence of maturation and hyperactivity-inattention","volume":"35","author":"Huijbregts","year":"2010","journal-title":"Dev Neuropsychol"},{"key":"B55","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.braindev.2015.08.001","article-title":"Motor impairment in children with neurofibromatosis type 1: effect of the comorbidity with language disorders","volume":"38","author":"Iannuzzi","year":"2016","journal-title":"Brain Dev"},{"key":"B56","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1007\/s10882-014-9375-3","article-title":"Relations between executive functioning and academic performance in adolescents with neurofibromatosis-1","volume":"26","author":"Janke","year":"2014","journal-title":"J Dev Phys Disabil"},{"key":"B57","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1002\/ajmg.b.32414","article-title":"Executive functioning deficits in children with neurofibromatosis type 1: the influence of intellectual and social functioning","author":"Plasschaert","year":"2016","journal-title":"Am J Med Genet B Neuropsychiatr Genet"},{"key":"B58","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1080\/13803395.2014.957166","article-title":"Relations between fine motor skill and parental report of attention in young children with neurofibromatosis type 1","volume":"36","author":"Casnar","year":"2014","journal-title":"J Clin Exp Neuropsychol"},{"key":"B59","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1111\/apa.12946","article-title":"Teenagers and young adults with neurofibromatosis type 1 are more likely to experience loneliness than siblings without the illness","volume":"104","author":"Ejerskov","year":"2015","journal-title":"Acta Paediatr"},{"key":"B60","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.ridd.2014.10.004","article-title":"Activity and participation in children with neurofibromatosis type 1","author":"Johnson","year":"2014","journal-title":"Res Dev Disabil"},{"key":"B61","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1002\/ajmg.b.32095","article-title":"Detecting anxiety symptoms in children and youths with neurofibromatosis type I","author":"Pasini","year":"2012","journal-title":"Am J Med Genet B Neuropsychiatr Genet"},{"key":"B62","doi-asserted-by":"publisher","first-page":"2103","DOI":"10.1002\/ajmg.a.37123","article-title":"Pain interference in youth with neurofibromatosis type 1 and plexiform neurofibromas and relation to disease severity, social-emotional functioning, and quality of life","author":"Wolters","year":"2015","journal-title":"Am J Med Genet A"},{"key":"B63","doi-asserted-by":"publisher","first-page":"1400","DOI":"10.1177\/0883073813500849","article-title":"Prevalence of sleep disturbances in children with neurofibromatosis type 1","volume":"28","author":"Licis","year":"2013","journal-title":"J Child Neurol"},{"key":"B64","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1093\/jpepsy\/jsr124","article-title":"Social-emotional functioning of children and adolescents with neurofibromatosis type 1 and plexiform neurofibromas: relationships with cognitive, disease, and environmental variables","volume":"37","author":"Martin","year":"2012","journal-title":"J Pediatr Psychol"},{"key":"B65","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1016\/j.jpeds.2015.04.075","article-title":"Distribution and within-family specificity of quantitative autistic traits in patients with neurofibromatosis type I","volume":"167","author":"Constantino","year":"2015","journal-title":"J Pediatr"},{"key":"B66","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1111\/dmcn.12043","article-title":"Autism and other psychiatric comorbidity in neurofibromatosis type 1: evidence from a population-based study","volume":"55","author":"Garg","year":"2013","journal-title":"Dev Med Child Neurol"},{"key":"B67","doi-asserted-by":"publisher","first-page":"1706","DOI":"10.1002\/ajmg.a.36549","article-title":"Screening children with neurofibromatosis type 1 for autism spectrum disorder","author":"Tinker","year":"2014","journal-title":"Am J Med Genet A"},{"key":"B68","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1080\/87565640903265137","article-title":"Thalamo-striatal T2-weighted hyperintensities (unidentified bright objects) correlate with cognitive impairments in neurofibromatosis type 1 during childhood","volume":"34","author":"Chabernaud","year":"2009","journal-title":"Dev Neuropsychol"},{"key":"B69","doi-asserted-by":"publisher","first-page":"1725","DOI":"10.1212\/01.WNL.0000098881.95854.5F","article-title":"Neurofibromatosis type 1: motor and cognitive function and T2-weighted MRI hyperintensities","volume":"61","author":"Feldmann","year":"2003","journal-title":"Neurology"},{"key":"B70","doi-asserted-by":"publisher","first-page":"1657","DOI":"10.1111\/j.1651-2227.2010.01923.x","article-title":"Development of MRI T2 hyperintensities and cognitive functioning in patients with neurofibromatosis type 1","volume":"99","author":"Feldmann","year":"2010","journal-title":"Acta Paediatr"},{"key":"B71","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1136\/jnnp.2006.108134","article-title":"T2 hyperintensities in children with neurofibromatosis type 1 and their relationship to cognitive functioning","volume":"78","author":"Hyman","year":"2007","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"B72","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1007\/s00431-014-2366-7","article-title":"Brain imaging findings and social\/emotional problems in Israeli children with neurofibromatosis type 1","volume":"174","author":"Cohen","year":"2015","journal-title":"Eur J Pediatr"},{"key":"B73","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1002\/acn3.288","article-title":"A randomized placebo-controlled lovastatin trial for neurobehavioral function in neurofibromatosis I","volume":"3","author":"Bearden","year":"2016","journal-title":"Ann Clin Transl Neurol"},{"key":"B74","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1002\/pds.564","article-title":"Methylphenidate in children with hyperactivity: review and cost-utility analysis","volume":"10","author":"Gilmore","year":"2001","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"B75","first-page":"1475","article-title":"How efficacious and safe is short-acting methylphenidate for the treatment of attention-deficit disorder in children and adolescents? A meta-analysis","volume":"165","author":"Schachter","year":"2001","journal-title":"CMAJ"},{"key":"B76","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1017\/S1355617709090481","article-title":"Why IQ is not a covariate in cognitive studies of neurodevelopmental disorders","volume":"15","author":"Dennis","year":"2009","journal-title":"J Int Neuropsychol Soc"}],"container-title":["Frontiers in Pediatrics"],"original-title":[],"link":[{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fped.2017.00227\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,10,30]],"date-time":"2017-10-30T04:16:31Z","timestamp":1509336991000},"score":1,"resource":{"primary":{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fped.2017.00227\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10,30]]},"references-count":76,"alternative-id":["10.3389\/fped.2017.00227"],"URL":"https:\/\/doi.org\/10.3389\/fped.2017.00227","relation":{},"ISSN":["2296-2360"],"issn-type":[{"value":"2296-2360","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,10,30]]},"article-number":"227"}}